Soros Fund Management’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-535,400
Closed -$37.8M – 318
2026
Q2
$37.8M Buy
+535,400
New +$28.9M 0.46% 67
2017
Q3
– Sell
-8,000
Closed -$235K – 267
2017
Q2
$235K Buy
+8,000
New +$219K ﹤0.01% 184
2016
Q2
– Sell
-72,000
Closed -$1.7M – 244
2016
Q1
$1.7M Buy
+72,000
New +$1.59M 0.04% 143
2015
Q4
– Sell
-22,000
Closed -$509K – 307
2015
Q3
$509K Buy
+22,000
New +$552K 0.01% 199

Other funds holding TECH

Soros Fund Management's TECH Position: Q3 2026 in Review

Soros Fund Management sold out of Bio-Techne (TECH) in Q3 2026, closing a stake of 535,400 shares — an estimated $37.8M sold.

Soros Fund Management first reported a position in TECH in Q3 2015 and held it in 4 quarters. The position peaked at $37.8M in Q2 2026. 577 funds tracked by Wall St. Rank hold TECH as of Q3 2026.

  • Soros Fund Management reported no remaining Bio-Techne position as of Q3 2026 after selling out during the quarter.
  • Soros Fund Management sold 535,400 Bio-Techne shares in Q3 2026, an estimated $37.8M.
  • Soros Fund Management first reported a position in Bio-Techne in Q3 2015 and held it in 4 quarters.
  • Soros Fund Management's Bio-Techne position peaked at $37.8M in Q2 2026.
  • 577 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2026.

Based on Soros Fund Management's 13F filing for Q3 2026, filed 13 Nov 2026.